I-Erlotinib Hydrochloride CAS 183319-69-9 Ubunyulu > 99.0% (HPLC)
Umvelisi ohamba phambili kunye nomthengisi we-Erlotinib Hydrochloride Intermediates
I-Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis (2-Methoxyethoxy)-3H-Quinazolin-4-enye CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Igama leMchiza | I-Erlotinib Hydrochloride |
Izithethantonye | I-Erlotinib HCl;Tarceva;CP-358774 Hydrochloride;I-6,7-Bis (2-methoxyethoxy) -4- (3-ethynylanilino) i-quinazoline Hydrochloride;N-(3-Ethynylphe nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl |
Inombolo yeCAS | 183319-69-9 |
Inombolo yeCAT | RF-PI2242 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C22H24ClN3O4 |
Ubunzima beMolekyuli | 429.90 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder |
Ukuchongwa | A: IR: Ihambelana neSpectrum yeReferensi B: I-HPLC: Ihambelana ne-Reference RT |
Ukunyibilika | Inyibilika kancinane kakhulu emanzini, iNyibilika kancinane kwiMethanol kwaye ayiNyibiliki ngokweAcetonitrile, iAcetone, iEthyl acetate kunye neHexane |
Indawo yokunyibilika | 223.0 ~ 229.0℃ |
Ilahleko ekomisweni | <0.50% |
Intsalela kwi-Ignition | <0.20% |
Iintsimbi ezinzima | <20ppm |
Ukungacoceki Okukodwa | <0.50% |
Ukungcola ngokupheleleyo | <1.00% |
Izinyibilikisi ezishiyekileyo | |
I-Pyridine | <4000ppm |
I-Chloroform | <4000ppm |
I-DMF | <3000ppm |
Ubunyulu / Indlela yokuHlalutya | >99.0% |
Indlela yoVavanyo / yoHlahlelo | 98.5% ~ 101.0% (Ibalwe kwiSiseko esingenamanzi) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma


I-Erlotinib Hydrochloride (CAS: 183319-69-9) yimolekyuli encinci ye-epidermal growth factor receptor tyrosine kinase reversible inhibitor, isetyenziswa ikakhulu kunyango lomhlaza wemiphunga weseli ohamba phambili okanye we-metastatic ongewona omncinci weseli kunye nomgca wesibini okanye unyango lwemigca emithathu. umhlaza wepancreatic.I-Erlotinib Hydrochloride yamkelwa ngoNovemba, 2004, kunyango lomhlaza wemiphunga ophezulu okanye we-metastatic ongeyonxalenye encinci.Kukwiklasi efanayo ne-Gefitinib, enye i-quinazoline evunyiweyo kunyango lomhlaza wemiphunga ophezulu, kodwa ngeempawu eziphuculweyo ze-pharmacokinetic.I-molecule yaqalwa nguPfizer kwaye uphuhliso lwaqalwa ngokubambisana ne-OSI, eyathatha amalungelo apheleleyo kwichiza xa iPfizer idityaniswa noWarner Lambert.Emva koko, i-Genentech/Roche yangena kwisivumelwano selayisensi ne-OSI ukuphuhlisa nokuthengisa ichiza e-US nakwihlabathi liphela.I-epidermal growth factor receptor ekhethiweyo (EGFR) -tyrosine kinase inhibitor.I-Antineoplastic.I-Erlotinib Hydrochloride yi-HER1/EGFR inhibitor ene-IC50 ye-2 nM.I-Erlotinib HCl ifumaneka njenge-25-, 100-, kunye ne-150-mg iipilisi zolawulo lomlomo.
-
I-Erlotinib Hydrochloride CAS 183319-69-9 Ubunyulu ...
-
3-Ethynylaniline CAS 54060-30-9 Ubunyulu > 99.0% (...
-
6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone CA...
-
3-Aminophenylacetylene HCl CAS 207726-02-6 Puri...
-
I-4-Ethynyltoluene CAS 766-97-2 Ubunyulu > 98.0% (GC)
-
4-Bromophenylacetylene CAS 766-96-1 Ubunyulu > 99....
-
Ethynylbenzene Phenylacetylene CAS 536-74-3 Pur...